Helius Medical Technologies has launched an online training module for physical therapists who wish to use the company’s…
Articles by Lindsey Shapiro, PhD
A six-week program combining yoga and group discussions about resilience led to significant reductions in fatigue and anxiety, and improvements…
Sepsis, a life-threatening response to an infection that can result in tissue damage and organ failure, was reported in nearly…
Delaying the start of disease-modifying therapies (DMTs) increases the risk of people with relapsing-remitting multiple sclerosis (RRMS) needing…
Smoking is associated with lower brain volume, more brain lesions, and greater disability and attention deficits among people with…
Lower levels of income and education, as well as other socioeconomic factors, are associated with the presence and severity of…
An assistive device made it significantly easier and more comfortable for multiple sclerosis (MS) patients with arm and hand…
The U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on Phase 3 trials testing the investigational…
Fatigue is a common symptom among people living with multiple sclerosis (MS), and has a significant negative impact on…
The Phase 3 RELEASE MSS1 clinical trial testing nabiximols oral spray failed to meet its primary goal of easing…
OM1 has created an artificial intelligence (AI)-based algorithm to estimate scores on the expanded disability status scale (EDSS),…
Ublituximab, an investigational antibody-based treatment for multiple sclerosis (MS), was efficacious across most patient subgroups, and led to marked…
A short course of high-dose methylprednisolone was associated with signs of mild liver injury in nearly 3% of multiple…
Autologous hematopoietic stem cell transplant (aHSCT) has shown some promise as a treatment option for highly active relapsing-remitting…
The risk of erectile dysfunction was about three times greater in men with multiple sclerosis (MS) compared with healthy…
The Multiple Sclerosis Society of Canada has opened MS Bike, an annual cycling event to raise awareness and funds for…
Alcohol intake is not significantly associated with an increased risk of developing multiple sclerosis (MS), but specifically drinking beer…
Cresence AS has sold its epidermal growth factor (EGF) platform comprising investigational therapies for multiple sclerosis (MS)…
The U.S. Food and Drug Administration has given Ekso Bionics clearance to market its wearable robotic exoskeleton to aid…
Treatment with Evusheld (tixagevimab co-packaged with cilgavimab) after COVID-19 vaccination significantly boosted the levels of antibodies against the virus…
A protein called nephronectin mediates autoimmunity in a mouse model of multiple sclerosis (MS), and blocking this protein was…
A blood biomarker test developed by Octave can effectively monitor overall disease activity in people with multiple sclerosis…
A single infusion of FibroBiologics‘ investigational cell therapy, CYMS101, was able to inhibit disease activity in a mouse…
The U.S. Department of Defense (DOD) has awarded $3.9 million to fund clinical research to test the impact of a…
Repeated fecal transplants from healthy donors were safe and well-tolerated in a small group of people with relapsing-remitting multiple…
A five-week, high-intensity video game-based exercise program called exergaming outperformed other forms of exercise at easing symptoms and improving life…
Persistent use of a single disease-modifying therapy (DMT) over a three-year period was low among people with relapsing forms…
Genetic variants that contribute to a high body mass index (BMI) during childhood are associated with an increased risk of developing…
Aquatic exercise is used less often by people with multiple sclerosis (MS) than land-based exercise, but it’s generally well…
Gilenya (fingolimod) and Tysabri (natalizumab) were more effective at lowering relapse rates in children with multiple sclerosis…